Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke

An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard treatment.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news139410726.html">Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke</a></p> <p>An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard treatment.</p>